| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NITE | Nightstar Therapeutics plc | Whitcup Scott M | Director | Jun 07, 2019 | Option Exercise | $25.50 | 74,568 | 1,901,484 | 0 | Jun 07, 2019, 04:41 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Feb 20, 2015 | Option Exercise | $234.00 | 80 | 18,720 | 17,175 | Feb 24, 2015, 09:48 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Feb 14, 2014 | Option Exercise | $124.57 | 284 | 35,378 | 17,043 | Feb 19, 2014, 02:45 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Jan 14, 2014 | Option Exercise | $55.97 | 42,000 | 2,350,950 | 59,327 | Jan 15, 2014, 06:24 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Jan 14, 2014 | Sale | $117.80 | 42,000 | 4,947,600 | 38,327 | Jan 15, 2014, 06:24 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Jan 08, 2014 | Option Exercise | $55.97 | 42,000 | 2,350,950 | 59,327 | Jan 10, 2014, 06:37 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Jan 08, 2014 | Sale | $113.80 | 42,000 | 4,779,600 | 38,327 | Jan 10, 2014, 06:37 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Jan 03, 2014 | Option Exercise | $36.15 | 24,200 | 874,830 | 41,527 | Jan 07, 2014, 05:08 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Jan 03, 2014 | Sale | $111.80 | 24,200 | 2,705,560 | 17,327 | Jan 07, 2014, 05:08 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Dec 20, 2013 | Sale | $108.80 | 33,000 | 3,590,400 | 17,327 | Jan 06, 2014, 06:27 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Dec 20, 2013 | Option Exercise | $36.15 | 33,000 | 1,192,950 | 33,827 | Dec 20, 2013, 07:41 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Dec 20, 2013 | Sale | $108.80 | 33,000 | 3,590,400 | 17,327 | Dec 20, 2013, 07:41 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Apr 11, 2013 | Sale | $115.00 | 12,005 | 1,380,575 | 17,327 | Apr 15, 2013, 04:00 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Apr 11, 2013 | Option Exercise | $36.15 | 12,005 | 433,981 | 29,332 | Apr 15, 2013, 04:00 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Apr 03, 2013 | Option Exercise | $36.15 | 13,195 | 476,999 | 30,522 | Apr 05, 2013, 05:05 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Apr 03, 2013 | Sale | $115.00 | 13,195 | 1,517,425 | 17,327 | Apr 05, 2013, 05:05 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Apr 01, 2013 | Option Exercise | $41.24 | 8,000 | 329,920 | 25,327 | Apr 02, 2013, 02:37 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Apr 01, 2013 | Sale | $111.70 | 8,000 | 893,624 | 17,327 | Apr 02, 2013, 02:37 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Mar 26, 2013 | Option Exercise | $36.15 | 11,484 | 415,147 | 28,811 | Mar 27, 2013, 07:11 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Mar 26, 2013 | Sale | $112.00 | 11,484 | 1,286,208 | 17,327 | Mar 27, 2013, 07:11 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Mar 21, 2013 | Option Exercise | $36.15 | 1,191 | 43,055 | 18,518 | Mar 25, 2013, 06:41 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Mar 21, 2013 | Sale | $112.00 | 1,191 | 133,392 | 17,327 | Mar 25, 2013, 06:41 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Mar 25, 2013 | Option Exercise | $36.15 | 4,925 | 178,039 | 22,252 | Mar 25, 2013, 06:41 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Mar 25, 2013 | Sale | $112.00 | 4,925 | 551,600 | 17,327 | Mar 25, 2013, 06:41 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Feb 20, 2013 | Option Exercise | $108.08 | 5,218 | 563,961 | 17,327 | Feb 22, 2013, 07:17 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Feb 15, 2013 | Option Exercise | $108.02 | 434 | 46,881 | 22,545 | Feb 20, 2013, 08:30 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Jan 04, 2013 | Sale | $96.80 | 24,000 | 2,323,200 | 22,979 | Jan 07, 2013, 07:16 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Jan 04, 2013 | Option Exercise | $41.24 | 24,000 | 989,760 | 46,979 | Jan 07, 2013, 07:16 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Dec 07, 2012 | Option Exercise | $30.13 | 6,800 | 204,850 | 29,779 | Dec 11, 2012, 07:50 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Dec 07, 2012 | Sale | $91.23 | 6,800 | 620,391 | 22,979 | Dec 11, 2012, 07:50 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Oct 17, 2012 | Option Exercise | $30.13 | 5,000 | 150,625 | 27,979 | Oct 18, 2012, 05:12 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Oct 17, 2012 | Sale | $94.70 | 5,000 | 473,500 | 22,979 | Oct 18, 2012, 05:12 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Oct 01, 2012 | Sale | $92.70 | 6,000 | 556,200 | 22,979 | Oct 02, 2012, 08:11 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Oct 01, 2012 | Option Exercise | $30.13 | 6,000 | 180,750 | 28,979 | Oct 02, 2012, 08:11 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | May 30, 2012 | Option Exercise | $30.13 | 1,500 | 45,188 | 24,479 | May 31, 2012, 06:35 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | May 30, 2012 | Sale | $90.71 | 1,500 | 136,062 | 22,979 | May 31, 2012, 06:35 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | May 16, 2012 | Option Exercise | $30.13 | 1,500 | 45,188 | 24,479 | May 18, 2012, 02:55 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | May 16, 2012 | Sale | $92.00 | 1,500 | 138,000 | 22,979 | May 18, 2012, 02:55 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Feb 22, 2012 | Option Exercise | $87.27 | 45 | 3,927 | 22,979 | Feb 24, 2012, 06:40 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Feb 14, 2012 | Option Exercise | $88.11 | 1,470 | 129,514 | 22,480 | Feb 16, 2012, 07:13 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | May 18, 2011 | Option Exercise | $28.92 | 5,500 | 159,060 | 29,450 | May 19, 2011, 02:36 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | May 18, 2011 | Sale | $83.89 | 5,500 | 461,400 | 23,950 | May 19, 2011, 02:36 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | May 11, 2011 | Sale | $80.85 | 608 | 49,156 | 23,950 | May 12, 2011, 08:05 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | May 04, 2011 | Option Exercise | $28.92 | 2,000 | 57,840 | 26,558 | May 05, 2011, 08:15 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | May 04, 2011 | Sale | $80.80 | 2,000 | 161,600 | 24,558 | May 05, 2011, 08:15 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Feb 17, 2011 | Sale | $75.72 | 4,000 | 302,891 | 23,728 | Feb 18, 2011, 05:30 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Dec 14, 2010 | Option Exercise | $40.09 | 15,020 | 602,132 | 42,748 | Dec 15, 2010, 06:24 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Dec 14, 2010 | Sale | $69.48 | 15,020 | 1,043,608 | 27,728 | Dec 15, 2010, 06:24 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Dec 01, 2010 | Sale | $67.14 | 7,400 | 496,847 | 27,728 | Dec 02, 2010, 06:49 PM | |
| AGN | ALLERGAN INC | Whitcup Scott M | Executive VP, R&D, CSO | Dec 01, 2010 | Option Exercise | $40.09 | 7,400 | 296,656 | 35,128 | Dec 02, 2010, 06:49 PM |
Menu